“Managing biopharmaceutical manufacturing in cost efficient manner through contract services”2016 witnessed a continued increase in contract manufacturing operations with an objective to cut back on in-house costs and capacity while maintaining the product quality and timelines. With growing pressure of biopharmaceutical demand and R&D costs, CMOs/CROs have significantly grown to gain ground in biopharmaceutical industry.Outsourcing... Continue Reading →

The global BIOPHARMACEUTICAL CMO & CRO (CONTRACT MANUFACTURING & RESEARCH) MARKET is expected to reach USD 37.8 billion by 2025, according to a new report by Grand View Research, Inc. Healthy outlook of biopharmaceuticals and consequent growth in biopharmaceutical pipelines has resulted into lack of adequate capacity and budget constraints. These factors have convinced many traditional drug... Continue Reading →